Oestrogen-mediated suppression of tumour necrosis factor alpha-induced apoptosis in MCF-7 cells: subversion of Bcl-2 by anti-oestrogens.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Steroid Biochemistry and Molecular Biology

• Publication date

  2001-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0960-0760(01)00117-0PMID 11738551
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity.

  2001cited by this paper
• Rapid actions of plasma membrane estrogen receptors.

  2001influential reference
• Phosphatidylinositol 3‐kinase mediates neuroprotection by estrogen in cultured cortical neurons

  2000cited by this paper
• The tyrosine kinase and mitogen-activated protein kinase pathways mediate multiple effects of estrogen in hippocampus.

  2000influential reference
• Cross-talk between Phosphatidylinositol 3-Kinase and Sphingomyelinase Pathways as a Mechanism for Cell Survival/Death Decisions*

  2000cited by this paper
• Activation of the p38 mitogen-activated protein kinase pathway by estrogen or by 4-hydroxytamoxifen is coupled to estrogen receptor-induced apoptosis.

  2000cited by this paper
• 17β-Estradiol Inhibits Apoptosis in MCF-7 Cells, Inducing bcl-2 Expression via Two Estrogen-Responsive Elements Present in the Coding Sequence

  2000cited by this paper
• Estrogen Signals to the Preservation of Endothelial Cell Form and Function*

  2000influential reference
• Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells.

  2000influential reference
• Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer.

  2000influential reference
• Tamoxifen-induced apoptosis in breast cancer cells relates to down-regulation of bcl-2, but not bax and bcl-X(L), without alteration of p53 protein levels.

  1999cited by this paper
• Time‐related effects of estrogen withdrawal on proliferation‐ and cell death‐related events in MCF‐7 xenografts

  1999cited by this paper
• Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD.

  1999cited by this paper
• The pure antiestrogen ICI 182780 is more effective in the induction of apoptosis and down regulation of BCL‐2 than tamoxifen in MCF‐7 cells

  1999cited by this paper
• Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.

  1999influential reference
• Role of AKT1 in 17β-estradiol- and insulin-like growth factor I (IGF-I)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells

  1999cited by this paper
• Effects of environmental estrogens on tumor necrosis factor α-mediated apoptosis in MCF-7 cells

  1999influential reference
• Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium.

  1999influential reference
• Effects of environmental estrogens on tumor necrosis factor alpha-mediated apoptosis in MCF-7 cells.

  1999cited by this paper
• BCL-2 Is Phosphorylated and Inactivated by an ASK1/Jun N-Terminal Protein Kinase Pathway Normally Activated at G2/M

  1999cited by this paper
• Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines

  1999cited by this paper
• Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells.

  1999cited by this paper
• Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis.

  1999cited by this paper
• Novel mechanisms of estrogen action in the brain: new players in an old story.

  1999cited by this paper
• Mechanisms of Transcriptional Activation of bcl-2Gene Expression by 17β-Estradiol in Breast Cancer Cells*

  1999cited by this paper
• Role of AKT1 in 17beta-estradiol- and insulin-like growth factor I (IGF-I)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells.

  1999cited by this paper
• Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug‐resistant cancer cells

  1999cited by this paper
• Cross-talk between peptide growth factor and estrogen receptor signaling pathways.

  1998cited by this paper
• Basic guide to the mechanisms of antiestrogen action.

  1998cited by this paper
• Estrogen withdrawal‐induced human breast cancer tumour regression in nude mice is prevented by Bcl‐2

  1998cited by this paper
• Tamoxifen induces selective membrane association of protein kinase C epsilon in MCF‐7 human breast cancer cells

  1998cited by this paper
• Hormonal control of programmed cell death/apoptosis.

  1998cited by this paper
• Dysregulation of apoptosis in cancer.

  1998cited by this paper
• Granulocyte-macrophage colony-stimulating factor rescues TF-1 leukemia cells from ionizing radiation-induced apoptosis through a pathway mediated by protein kinase Calpha.

  1998cited by this paper
• Granulocyte-Macrophage Colony-Stimulating Factor Rescues TF-1 Leukemia Cells From Ionizing Radiation-Induced Apoptosis Through a Pathway Mediated by Protein Kinase Cα

  1998cited by this paper
• Apoptosis in the mammary gland and breast cancer

  1998cited by this paper
• Recent advances in understanding the molecular mechanisms of tamoxifen action.

  1998cited by this paper
• Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants.

  1998influential reference
• Signal transduction during apoptosis; implications for cancer therapy.

  1998cited by this paper
• Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells

  1997cited by this paper
• Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancer

  1997cited by this paper
• Activation of Signal Transduction Kinases by Tamoxifen

  1997cited by this paper
• Bcl-2 Undergoes Phosphorylation by c-Jun N-terminal Kinase/Stress-activated Protein Kinases in the Presence of the Constitutively Active GTP-binding Protein Rac1*

  1997cited by this paper
• Insulin-like growth factor binding protein-3 induces apoptosis in MCF7 breast cancer cells.

  1997influential reference
• Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy.

  1996cited by this paper
• Overexpression of HER2 modulates bcl-2, bcl-XL, and tamoxifen-induced apoptosis in human MCF-7 breast cancer cells.

  1996cited by this paper
• Tyrosine kinase/p21ras/MAP‐kinase pathway activation by estradiol‐receptor complex in MCF‐7 cells.

  1996cited by this paper
• TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB.

  1996cited by this paper
• TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB

  1996cited by this paper
• Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells

  1995cited by this paper
• Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells.

  1995cited by this paper
• Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7.

  1995influential reference
• MCF‐7 human mammary adenocarcinoma cell death in vitro in response to hormone‐withdrawal and dna damage

  1995cited by this paper
• Growth factors in breast cancer.

  1995cited by this paper
• Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells.

  1995cited by this paper
• Inactivation of Bcl-2 by phosphorylation.

  1995cited by this paper
• Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma.

  1995cited by this paper
• Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1

  1994cited by this paper
• Effect of bcl-2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity.

  1993cited by this paper
• Apoptotic cell death and tissue remodelling during mouse mammary gland involution.

  1992cited by this paper
• Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation.

  1991cited by this paper
• Activation of programmed cell death in the rat ventral prostate after castration.

  1988cited by this paper
• Morphological evaluation of cell turnover in relation to the menstrual cycle in the "resting" human breast.

  1981cited by this paper

• ERβ1 Sensitizes and ERβ2 Desensitizes ERα-Positive Breast Cancer Cells to the Inhibitory Effects of Tamoxifen, Fulvestrant and Their Combination with All-Trans Retinoic Acid

  2023cites this paper
• Regulatory Crosstalk of Doxorubicin, Estradiol and TNFα Combined Treatment in Breast Cancer-derived Cell Lines

  2019cites this paper
• A preliminary study of 18F-FES PET/CT in predicting metastatic breast cancer in patients receiving docetaxel or fulvestrant with docetaxel

  2017cites this paper
• Alterations in estrogen signalling pathways upon acquisition of anthracycline resistance in breast tumor cells

  2017cites this paper
• articleThe estrogen receptor influences microtubule-associated protein tau ( MAPT ) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells

  2015cites this paper
• Estrogen Regulation of Anti-Apoptotic Bcl-2 Family Member Mcl-1 Expression in Breast Cancer Cells

  2014cites this paper
• Antiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alpha.

  2012cites this paper
• BIK/NBK gene as potential marker of prognostic and therapeutic target in breast cancer patients

  2012cites this paper
• Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5‐fluorouracil) has a synergistic effect in estrogen receptor‐positive breast cancer

  2011cites this paper
• The effects of estrogen and phytoestrogens on focal infarct, PTEN, and p-AKT expression in aged rats.

  2010cites this paper
• Short communication The ERα coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium

  2010cites this paper
• The ERα coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium

  2010cites this paper
• BCL-2 family function in antiestrogen-resistant breast cancer cells

  2009cites this paper
• pposing actions of the progesterone metabolites , 5-dihydroprogesterone 5 P ) and 3-dihydroprogesterone ( 3 HP ) on mitosis , apoptosis , and expression f Bcl-2 , Bax and p 21 in human breast cell lines

  2009cites this paper
• L1 mobile element expression causes multiple types of toxicity.

  2008influential citation
• TNFα-induced Down-Regulation of Estrogen Receptor α in MCF-7 Breast Cancer Cells

  2008cites this paper
• Antioestrogen-mediated cell cycle arrest and apoptosis induction in breast cancer and multiple myeloma cells.

  2008cites this paper
• TNF alpha-induced down-regulation of estrogen receptor alpha in MCF-7 breast cancer cells.

  2008cites this paper
• Sex Hormone-binding Globulin Selectively Modulates Estradiol-regulated Genes in MCF-7 Cells

  2007cites this paper
• BP1 transcriptionally activates bcl-2 and inhibits TNFα-induced cell death in MCF7 breast cancer cells

  2007cites this paper
• The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells.

  2006cites this paper
• Coregulation of estrogen receptor by ERBB4/HER4 establishes a growth-promoting autocrine signal in breast tumor cells.

  2006cites this paper
• The ERBB 4 / HER 4 Intracellular Domain 4 ICD Is a BH 3-Only Protein Promoting Apoptosis of Breast Cancer Cells

  2006cites this paper
• Phosphorylation of MNAR Promotes Estrogen Activation of Phosphatidylinositol 3-Kinase

  2006cites this paper
• TITLE: ErbB4 Overexpression as an Antagonist of ErbB2/HER2/Neu Induced Human Breast Cancer Cell Proliferation

  2006cites this paper
• Phosphorylation of MNAR Promotes Estrogen Activation of PI3 Kinase

  2006cites this paper
• Molecular Effects of Genistein on Proliferation and Apoptosis of MCF-7 Cell Line

  2006cites this paper
• ERBB4/HER4 Potentiates STAT5A Transcriptional Activity by Regulating Novel STAT5A Serine Phosphorylation Events*[boxs]

  2005cites this paper
• Breast Cancer Progression: A “Vicious Cycle” of Pro-Malignancy Activities is Mediated by Inflammatory Cells, Chemokines and Cytokines

  2005cites this paper
• Presenilin-dependent γ-Secretase Processing Regulates Multiple ERBB4/HER4 Activities*

  2005cites this paper
• Osteoprotegerin (OPG) Expression by Breast Cancer Cells in vitro and Breast Tumours in vivo – A Role in Tumour Cell Survival?

  2005cites this paper
• Antiestrogens, aromatase inhibitors, and apoptosis in breast cancer.

  2005cites this paper
• Presenilin-dependent gamma-secretase processing regulates multiple ERBB4/HER4 activities.

  2005cites this paper
• 7. PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 8. PERFORMING ORGANIZATION REPORT NUMBER

  2005cites this paper
• Opposite effects of estrogen receptors alpha and beta on MCF-7 sensitivity to the cytotoxic action of TNF and p53 activity

  2005cites this paper
• Oestrogen inhibits resveratrol-induced post-translational modification of p53 and apoptosis in breast cancer cells

  2004cites this paper
• The ERBB 4 / HER 4 receptor tyrosine kinase regulates gene expression by functioning as a STAT 5 A nuclear chaperone

  2004influential citation
• Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling.

  2004cites this paper
• BAD is a Central Player in Cell Death and Cell Cycle Regulation in Breast Cancer Cells

  2004influential citation
• Regulation of estrogen-mediated cell survival and proliferation by p160 coactivators.

  2004cites this paper
• The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone

  2004cites this paper
• The Regulatory Roles of Estrogen in Carcinogenesis: an Overview

  2004cites this paper
• A prognostic index for operable, node-negative breast cancer

  2004cites this paper
• The Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis.

  2004cites this paper
• Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology.

  2003cites this paper
• Estrogen prevention of lacrimal gland cell death and lymphocytic infiltration.

  2003cites this paper
• Fulvestrant (Faslodex™): current status in the therapy of breast cancer

  2002cites this paper
• AD Award Number : DAMD 17-021-0596 TITLE : Potential Therapeutic Use of Glyceollins ( I-III ) , Novel Anti-Estrogenic Flavonoid Phytochemicals Isolated from Soy PRINCIPAL INVESTIGATOR :

  year unknowncites this paper
• Open Access Research Article

  year unknowncites this paper
• UNCLASSIFIED AD NUMBER ADB 283894 NEW LIMITATION CHANGE

  year unknowncites this paper